Sagimet Biosciences (SGMT) Institutional Ownership → Protect Yourself While There’s Still Time … (From Weiss Ratings) (Ad) Free SGMT Stock Alerts $4.06 +0.14 (+3.57%) (As of 04/26/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Sagimet Biosciences (NASDAQ:SGMT)CurrentInstitutional OwnershipPercentage87.86%Number ofInstitutional Buyers(last 12 months)11TotalInstitutional Inflows(last 12 months)$44.10MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$1.48M Get SGMT Insider Trade Alerts Want to know when executives and insiders are buying or selling Sagimet Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data SGMT Institutional Buying and Selling by Quarter Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> Sagimet Biosciences Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/14/2024Platinum Investment Management Ltd.111,752$606K0.0%-70.9%0.523% 2/5/2024Victory Capital Management Inc.56,570$307K0.0%+215.0%0.265% 1/31/2024Federated Hermes Inc.97,276$527K0.0%+24.7%0.455% 11/15/2023RTW Investments LP400,277$3.52M0.1%N/A1.875% 11/15/2023Rock Springs Capital Management LP738,355$6.50M0.2%N/A3.458% 11/14/2023Dumac Inc.204,123$1.80M4.8%N/A0.956% 11/13/2023CHI Advisors LLC348,842$3.07M0.9%N/A1.634% 11/13/2023Federated Hermes Inc.78,000$686K0.0%N/A0.365% 11/13/2023Silverarc Capital Management LLC100,000$880K0.3%N/A0.468% 11/13/2023FMR LLC2,672,355$23.52M0.0%N/A12.517% 11/7/2023New York State Common Retirement Fund6,357$56K0.0%N/A0.030% 11/6/2023Victory Capital Management Inc.17,960$158K0.0%N/A0.084% 11/3/2023Platinum Investment Management Ltd.383,913$3.38M0.1%N/A1.798% 10/31/2023Teacher Retirement System of Texas25,000$220K0.0%N/A0.117% (Data available from 1/1/2016 forward) SGMT Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of SGMT shares? During the previous two years, 11 institutional investors and hedge funds held shares of Sagimet Biosciences. The most heavily invested institutionals were FMR LLC ($23.52M), Rock Springs Capital Management LP ($6.50M), RTW Investments LP ($3.52M), CHI Advisors LLC ($3.07M), Dumac Inc. ($1.80M), Silverarc Capital Management LLC ($880K), and Platinum Investment Management Ltd. ($606K).Learn more on SGMT's institutional investors. What percentage of Sagimet Biosciences stock is owned by institutional investors? 87.86% of Sagimet Biosciences stock is owned by institutional investors. Learn more on SGMT's institutional investor holdings. Which institutional investors have been buying Sagimet Biosciences stock? Of the 11 institutional investors that purchased Sagimet Biosciences stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: FMR LLC ($2.67M), Rock Springs Capital Management LP ($738.36K), RTW Investments LP ($400.28K), Platinum Investment Management Ltd. ($383.91K), CHI Advisors LLC ($348.84K), Dumac Inc. ($204.12K), and Silverarc Capital Management LLC ($100K). How much institutional buying is happening at Sagimet Biosciences? Institutional investors have bought a total of 5,033,068 shares in the last 24 months. This purchase volume represents approximately $44.10M in transactions. Which Sagimet Biosciences major shareholders have been selling company stock? The following institutional investors have sold Sagimet Biosciences stock in the last 24 months: Platinum Investment Management Ltd. ($272.16K). How much institutional selling is happening at Sagimet Biosciences? Institutional investors have sold a total of 272,161 shares in the last 24 months. This volume of shares sold represents approximately $1.48M in transactions. Related Companies: Karyopharm Therapeutics Institutional Ownership Vistagen Therapeutics Institutional Ownership Coya Therapeutics Institutional Ownership Amylyx Pharmaceuticals Institutional Ownership InterCure Institutional Ownership PDS Biotechnology Institutional Ownership Citius Pharmaceuticals Institutional Ownership Repare Therapeutics Institutional Ownership Societal CDMO Institutional Ownership Nuvectis Pharma Institutional Ownership This page (NASDAQ:SGMT) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithFed launches fourth dollar overhaulStansberry ResearchBiden out June 13; Kamala won’t replace him?Paradigm PressMan Who Predicted 2008: “This Will be Worse.”AltimetryExposed: 10 CENT Crypto to Explode April 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sagimet Biosciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
